Patents by Inventor Jiang-Ping Wu

Jiang-Ping Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Small molecules useful in the treatment of inflammatory disease
    Publication number: 20030203955
    Abstract: A method for treating inflammatory and immune cell-mediated diseases by the administration of compounds of the formula I 1
    Type: Application
    Filed: July 16, 2002
    Publication date: October 30, 2003
    Applicant: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Jiang-Ping Wu, Terence Alfred Kelly, Rene M. Lemieux, Daniel R. Goldberg, Jonathan Emilian Emeigh, Ronald John Sorcek
  • Small molecules useful in the treatment of inflammatory disease
    Publication number: 20030008848
    Abstract: Compound of the formula I, II, III or IV 1
    Type: Application
    Filed: December 5, 2001
    Publication date: January 9, 2003
    Inventors: Roman Wolfgang Fleck, Terence Alfred Kelly, Jin Mi Kim, Jinbo Lee, Rene Marc Lemieux, Ronald John Sorcek, Jiang-Ping Wu
  • Small molecules useful in the treatment of inflammatory disease
    Patent number: 6492408
    Abstract: Compounds of the formula I which are useful for treating or preventing inflammatory and immune cell-mediated diseases.
    Type: Grant
    Filed: June 27, 2000
    Date of Patent: December 10, 2002
    Assignee: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Jiang-Ping Wu, Terence Alfred Kelly, Rene Lemieux, Daniel R. Goldberg, Jonathan Emilian Emeigh, Ronald John Sorcek
  • 1-phenylpydrrolidin-2-ones and -thiones and 1-(4-pyridyl)pydrrolidin-2-ones and -thiones which are useful in the treatment of inflammatory disease
    Patent number: 6414153
    Abstract: Novel compounds of the formula I: which are useful for treating or preventing inflammatory and immune cell-mediated diseases. Exemplary compounds are: 3-(4-bromobenzyl)-1-(3,5-dichlorophenyl)-1,3-dihydroindol-2-one; 3-(4-bromobenzyl)-1-(3,5-dichlorophenyl)-3-methyl-1,3-dihydro-indol-2-one; 3-benzyl-1-(3,5-dichlorophenyl)-3-methyl-1,3-dihydroindol-2-one; 3-(4-bromobenzyl)-1-(3,5-dichlorophenyl)-4-hydroxy-3-methyl-1,3-dihydroindol-2-one; and, 3-(4-bromobenzyl)-1-(3,5-dichlorophenyl)-5-fluoro-1,3-dihydroindol-2-one.
    Type: Grant
    Filed: June 28, 2000
    Date of Patent: July 2, 2002
    Assignee: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Terence Alfred Kelly, Jiang-Ping Wu, Daniel Kuzmich, Yancey David Ward, Leah Lynn Frye
  • Small molecules useful in the treatment of inflammatory disease
    Patent number: 6365615
    Abstract: Novel compounds of the formula I which are useful for treating or preventing inflammatory and immune cell-mediated diseases. Exemplary compounds are: 2-(3,5-Dichlorophenyl)-7-(R*)-phenyl-7a-(R*)-tetrahydropyrrolo[1,2-c]imidazole-1,3-dione; 2-(3,5-Dichlorophenyl)-7a-(R*)-methyl-7-(R*)-phenyl-tetrahydropyrrolo[1,2-c]imidazole-1,3-dione; and, 7-(R*)-(4-Bromophenyl)-2-(3,5-dichlorophenyl)-7a-(R*)-tetrahydropyrrolo[1,2-c]imidazole-1,3-dione.
    Type: Grant
    Filed: June 28, 2000
    Date of Patent: April 2, 2002
    Assignee: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Terence Alfred Kelly, Jiang-Ping Wu, Daniel Kuzmich
  • Phenylpyrrolidines, phenylimidazolidines, 3-phenyl-1,3-oxizolidines and 3-phenyl-1,3-thiazolidines and their use in the treatment of inflammatory disease
    Patent number: 6355664
    Abstract: A method treating or preventing inflammatory and immune cell-mediated diseases by the administration of certain novel and known small molecules.
    Type: Grant
    Filed: August 16, 1999
    Date of Patent: March 12, 2002
    Assignee: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Terence A. Kelly, Barbara Jean Bormann, Leah Lynn Frye, Jiang-Ping Wu
  • Phenylpyrrolidines, phenylimidazolidines,3-phenyl-1,3-oxizolidines and 3-phenyl-1,3-thiazolidines and their use in the treatment of inflammatory disease
    Patent number: RE38132
    Abstract: A method treating or preventing inflammatory and immune cell-mediated diseases by the administration of certain novel and known small molecules.
    Type: Grant
    Filed: June 12, 2002
    Date of Patent: June 3, 2003
    Assignee: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Terence A. Kelly, Barbara Jean Bormann, Leah Lynn Frye, Jiang-Ping Wu